• /
  • /
  • Advances and Innovations in Heart Failure (AIHF): A Textbook of Cardiology
Picture of Advances and Innovations in Heart Failure (AIHF): A Textbook of Cardiology

Advances and Innovations in Heart Failure (AIHF): A Textbook of Cardiology

Editors-in-Chief: HK Chopra, Navin C Nanda, Jagat Narula
$120.00

Salient Features

  • Advances and Innovations in Heart Failure is the first publication in the form of a Textbook of Cardiology
  • Over 250 contributors from India and abroad have contributed chapters in this book
  • Focuses on every aspect of cardiovascular imaging and intervention, thereby enhancing knowledge and has tremendous innovative and research potential of understanding advances and innovations in heart failure for the undergraduates, postgraduates, practicing cardiologists, endocrinologists, nephrologists, neurologists, critical care, pulmonologists, pediatricians, pediatric surgeons, physicians, cardiovascular surgeons, imaging experts and nutritionists, etc. Various Section of this book include Chapter on Clinical, Echo, Imaging, Coronary artery disease, Stroke, Arrhythmia, Hypertension, Valvular, Congenital heart disease, Metabolic, Nutritional, Cardio-oncology, Inflammatory disorders and heart failure including Rehabilitation, Legal and ethical issues and Future directions, etc.

Table of Contents

Buy as you go

Buy by the chapter and never pay more than the price of the full book.
Chapter 1: Heart Failure in Indian Scenarios: Issues and Challenges in 2019 and Beyond
Chapter 2: Pathophysiology and Prevention of LV Diastolic Heart Failure
Chapter 3: Heart Failure: From India to the Globe
Chapter 4: Trivandrum Heart Failure Registry
Chapter 5: The Importance of Physical Examination in Patients with Heart Failure
Chapter 6: Heart Failure: Bench to Bedside
Chapter 7: Myocarditis and Heart Failure
Chapter 8: Biomarkers of Heart Failure: Diagnostic, Prognostic and Therapeutic Implications
Chapter 9: Heart Failure and End Organ Damage
Chapter 10: Natural History and Prognostic Factors in Alcoholic Cardiomyopathy with Heart Failure
Chapter 11: Treatment Priorities in Heart Failure
Chapter 12: Optimizing Treatment in Heart Failure
Chapter 13: Nonpharmacologic Therapies in Heart Failure
Chapter 14: Self-Care in Heart Failure: Patient Empowerment for Better Management
Chapter 15: Endothelium in Heart Failure
Chapter 16: Therapies for HFPEF: Current Status and Future Directions
Chapter 17: Heart Failure with Preserved Ejection Fraction: Few Newer Insights
Chapter 18: Advanced Heart Failure: What is it? When to Refer?
Chapter 19: Digoxin in Heart Failure
Chapter 20: How to Choose Diuretics in Heart Failure
Chapter 21: Chlorthalidone: A Diuretic of First Choice in Hypertension and Heart Failure
Chapter 22: Angiotensin Receptor Blockers and Heart Failure
Chapter 23: Angiotensin-Converting Enzyme Inhibitor and Heart Failure
Chapter 24: Lipid Management in Heart Failure
Chapter 25: Statins and Heart Failure
Chapter 26: Beta-Blockers in Heart Failure
Chapter 27: Bisoprolol in Heart Failure
Chapter 28: Noacs, Atrial Fibrillation and Heart Failure
Chapter 29: Ivabradine: A Therapeutic Agent in Heart Failure
Chapter 30: Real-World Data on Use of Arni in HFREF
Chapter 31: Arni in Nyha Class II Heart Failure: What is the Evidence?
Chapter 32: Practical Use of Angiotensin-Neprilysin Inhibitor in Heart Failure
Chapter 33: Sacubitril-Valsartan Initiation as In-Hospital Therapy
Chapter 34: Arni in HF with Comorbidities
Chapter 35: Ischemic Mitral Regurgitation
Chapter 36: SGLT2 Inhibitor and HFREF
Chapter 37: Mineralocorticoid Antagonists in Heart Failure
Chapter 38: Acc/Aha/Hfsa Guideline Update in Heart Failure Pharmacotherapy
Chapter 39: Clinical Guidelines for Heart Failure with Preserved Ejection Fraction
Chapter 40: Clinical Guidelines for HFREF: Aha, Acc and Esc
Chapter 41: New Innovations in Systolic Assessment of Heart Failure
Chapter 42: Stem Cells and Gene Therapy in Heart Failure
Chapter 43: Advances in Drug Therapy in Heart Failure
Chapter 44: Cardiac Devices for Patients with Heart Failure
Chapter 45: Cardiogenic Shock: Diagnosis and Management
Chapter 46: The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries in Heart Failure
Chapter 47: Sleep Apnea and Heart Failure
Chapter 48: Emergency and Urgent Care in Heart Failure
Chapter 49: Heart Failure Care in Icu
Chapter 50: Heart Failure and Critical Care
Chapter 51: Usefulness of Three-Dimensional Echocardiography in Heart Failure
Chapter 52: 3D Echocardiography and Bnp Screening in Heart Failure
Chapter 53: Echocardiographic Assessment of Left Ventricular Hypertrophy and Left Atrial Volume in Heart Failure
Chapter 54: Diagnostic Prognostic and Therapeutic Implications of E/E' in Heart Failure
Chapter 55: Role of Echocardiography for Prognosis in Patients with Heart Failure
Chapter 56: Echocardiographic Evaluation of Heart Failure in Emergency
Chapter 57: Echocardiographic Evaluation of Lv, La, Rv, and Ra Strain in Heart Failure
Chapter 58: Echocardiographic Evaluation of La Stiffness Index, Rv and Ra Strain in Heart Failure
Chapter 59: Left Ventricular Dyssynchrony: Echocardiographic Evaluation and Treatment in Heart Failure
Chapter 60: Echocardiography in Dilated Cardiomyopathy
Chapter 61: Hypertrophic Obstructive Cardiomyopathy with Heart Failure: Echocardiographic Evaluation
Chapter 62: Echocardiographic Pericardial Effusion Evaluation in Heart Failure
Chapter 63: Echocardiographic Endomyocardial Fibrosis: Evaluation with Heart Failure
Chapter 64: Noninvasive Evaluation of Cardiac Amyloidosis and Sarcoidosis
Chapter 65: Telemedicine and Internet of Things Technology for Management of Heart Failure
Chapter 66: Cardiac Sarcoidosis: Diagnosis, Imaging, and Management
Chapter 67: Echocardiographic Pulmonary Embolism Evaluation with Heart Failure
Chapter 68: Computed Tomography Angiography in Heart Failure
Chapter 69: Role of Cardiac Magnetic Resonance Imaging in Heart Failure
Chapter 70: Nuclear Imaging and Heart Failure: New Frontiers
Chapter 71: Pulmonary Artery Catheter Guided Therapy in Heart Failure
Chapter 72: Myocardial Mechanics of Heart Failure with Preserved Ejection Fraction
Chapter 73: Unusual Cardiomyopathies
Chapter 74: Artificial Intelligence: Its Impact in the Management of Heart Failure
Chapter 75: Acute Coronary Syndromes and Heart Failure
Chapter 76: Stemi and Heart Failure
Chapter 77: Treatment of Stemi Paradigm Shift from Mortality to Heart Failure
Chapter 78: Pediatric Stroke and Heart Failure
Chapter 79: Advances and Innovations in Heart Failure
Chapter 80: Coronary Artery Bypass Graft in Heart Failure
Chapter 81: Heart Failure and Stroke
Chapter 82: Paroxysmal Tachycardia and Heart Failure
Chapter 83: Sudden Cardiac Death in Heart Failure
Chapter 84: Rhythm Disorders and Cardiac Transplant Patient
Chapter 85: Cardiac Resynchronization Therapy in Congestive Heart Failure: State of Art, Troubleshooting and Management
Chapter 86: Drug Switch or a Device: How Do I Decide?
Chapter 87: Use of Left Ventricular Assist Devices in Heart Failure
Chapter 88: Minimally Invasive Left Ventricular Assist Devices
Chapter 89: Newer Left Ventricular Assist Devices: Current Scenario
Chapter 90: Device Therapy in Heart Failure
Chapter 91: Durable Ventricular Assist Devices in Advanced Heart Failure
Chapter 92: Review Outcomes of Recent Device Trials in Heart Failure
Chapter 93: Cardiorenal Syndrome in Heart Failure
Chapter 94: Hypertension and Heart Failure as Stroke Risk Factors
Chapter 95: Heart Failure and Hypertension
Chapter 96: Bisoprolol in Heart Failure
Chapter 97: Echocardiographic Evaluation of Aortic Stenosis with Heart Failure
Chapter 98: Aortic Stenosis with Aortic Regurgitation and Heart Failure
Chapter 99: Mitral Regurgitation and Heart Failure
Chapter 100: Mitraclip in Functional Mitral Regurgitation
Chapter 101: Tricuspid Regurgitation and Heart Failure
Chapter 102: Pulmonary Hypertension and Heart Failure
Chapter 103: Pulmonary Stenosis, Pulmonary Regurgitation and Heart Failure: Diagnosis and Management Strategies
Chapter 104: Riociguat in Cteph with Heart Failure
Chapter 105: Rheumatic Heart Disease and Heart Failure
Chapter 106: Heart Support Devices in Heart Failure
Chapter 107: Acyanotic Congenital Heart Disease and Heart Failure
Chapter 108: Heart Failure in Congenital Cyanotic Heart Diseases
Chapter 109: Neonatal Heart Failure
Chapter 110: Prevention of Heart Failure in Children
Chapter 111: Pediatric Stroke and Heart Failure
Chapter 112: Heart Failure Management: New Strategies
Chapter 113: Obesity and Heart Failure
Chapter 114: Pregnancy and Heart Failure
Chapter 115: Hypothyroidism and Heart Failure
Chapter 116: Hyperthyroidism and Heart Failure
Chapter 117: Coenzyme Q10 Deficiency and Heart Failure
Chapter 118: Iron Deficiency and Heart Failure
Chapter 119: Echocardiography Evaluation of Heart Failure in Oncology
Chapter 120: Chemotherapy and Congestive Heart Failure: Role of Multimodality Imaging
Chapter 121: Heart Failure and Sepsis
Chapter 122: Extracorporeal Membrane Oxygenation and Heart Failure
Chapter 123: Heart Transplant and Heart Failure
Chapter 124: Exercise Training and Rehabilitation in Chronic Heart Failure
Chapter 125: Role of Yoga in Heart Failure
Chapter 126: Cardiac Rehabilitation after Ventricular Assist Device Implantation: A Worthwhile Exercise?
Chapter 127: Legal and Ethical Issues in Heart Failure
Chapter 128: Review Ongoing Drug and Device Trials in HFPEF